Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Investor Presentation 2021

Jun 7, 2021

61700_rns_2021-06-07_3c8bb4bf-74c5-412a-93a3-2838827b7a4c.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

June 7, 2021

BSE Ltd. Phiroze Jeejeebhoy Towers Dalai Street Mumbai 400 023 Scrip Code-524494 1

THRU ONLINE FILING

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra -(East). Mumbai-400051. Scrip Code: IPCALAB

Dear Sirs,

Sub: Intimation of Schedule of Analysts / Institutional Investors virtual Meeting

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is participating in the following virtual group meetings of Analysts / Institutional Investors with its management:

  • J. Organised by YES Securities India Ltd. on Monday, 7th June, 2021 between 4.00 p.m. to 5.00 p.m.
    1. Organised by Investec Capital Services (India) Pvt. Ltd. on Tuesday, 8th June, 2021 between 2.00 p.m. to 4.30 p.m.

Please note that in this'virtual meetings, only publicly available information will be shared with the Analysts/institutional investors.

This is for your information/record.

• Thanking you

Yours faithfully For Ipca Laboratories Limited

Harish P. Kamath Corporate Counsel & Company Secretary

Ipca Laboratories Ltd. www.ipca.com

125, Kandivli Industrial Estate,CIS No.328, Kandivli (West),Mumbai400067.(Maharashtra), India j T:+91 2262105000 R+91 2262105005 . Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | I: +91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837